ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 23.95 Delayed Data As of 3:59pm ET |  -0.66 / -2.68%Today’s Change | 12.24 Today|||52-Week Range 26.04 | +50.44% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 58.3M | 59.6M | 63.0M | 83.2M | |
| Cost of Goods Sold | 3.1M | 2.0M | 2.2M | 2.3M | ||
| Depreciation And Amortization | 751.0K | 782.0K | 785.0K | 695.0K | ||
| Operating Expenses | Gross Income | 54.5M | 56.7M | 60.0M | 80.2M | |
| General Expenses | 115.7M | 124.0M | 147.6M | 137.3M | ||
| Research And Development | 53.1M | 48.2M | 52.9M | 67.3M | ||
| Total Operating Expenses | 119.6M | 126.8M | 150.6M | 140.3M | ||
| Non-Operating Expenses | Operating Income | -61.3M | -67.3M | -87.6M | -57.1M | |
| Other Expenses | -1.7M | 127.0K | -229.0K | -12.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -61.8M | -65.5M | -84.9M | -54.6M | |
| Income Taxes | -376.0K | -14.0K | -375.0K | -365.0K | ||
| Net Income | -62.1M | -65.5M | -85.3M | -54.9M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 125.0M | 131.6M | 144.0M | 144.3M | |
| Shares To Calculate EPS Diluted | 125.0M | 131.6M | 144.0M | 144.3M | ||
| Earnings Per Share | EPS | -$0.50 | -$0.50 | -$0.59 | -$0.38 | |
| EPS Diluted | -$0.50 | -$0.50 | -$0.59 | -$0.38 | ||
